专家委员会加持+循证能力强化！“京东知医”迎全面升级

京东健康黑板报03-09

近日，京东健康旗下循证医学AI工具“京东知医”正式完成新一轮升级。此次升级以循证能力的深度强化为核心，同时京东健康专家委员会正式加入“京东知医”产品共建，进一步从专业权威性与临床可信度层面为产品保驾护航。自今年1月发布以来，“京东知医”凭借精准的临床循证与高效的科研辅助能力，受到广大医生的认可。目前，“知医”已全面集成于京东医生App，并向全体医生免费开放使用，无论是否已入驻京东健康平台，均可直接...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2618649942?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-09 15:36","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2618649942","market":"hk","top_or_hot":-1,"title":"专家委员会加持+循证能力强化！“京东知医”迎全面升级","media":"京东健康黑板报","content":"<div>\n<p>近日，京东健康旗下循证医学AI工具“京东知医”正式完成新一轮升级。此次升级以循证能力的深度强化为核心，同时京东健康专家委员会正式加入“京东知医”产品共建，进一步从专业权威性与临床可信度层面为产品保驾护航。自今年1月发布以来，“京东知医”凭借精准的临床循证与高效的科研辅助能力，受到广大医生的认可。目前，“知医”已全面集成于京东医生App，并向全体医生免费开放使用，无论是否已入驻京东健康平台，均可直接...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309165057a45af78b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>专家委员会加持+循证能力强化！“京东知医”迎全面升级</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n专家委员会加持+循证能力强化！“京东知医”迎全面升级\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-09 15:36 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309165057a45af78b&s=b><strong>京东健康黑板报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，京东健康旗下循证医学AI工具“京东知医”正式完成新一轮升级。此次升级以循证能力的深度强化为核心，同时京东健康专家委员会正式加入“京东知医”产品共建，进一步从专业权威性与临床可信度层面为产品保驾护航。自今年1月发布以来，“京东知医”凭借精准的临床循证与高效的科研辅助能力，受到广大医生的认可。目前，“知医”已全面集成于京东医生App，并向全体医生免费开放使用，无论是否已入驻京东健康平台，均可直接...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309165057a45af78b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0048580855.USD","symbol_name":"富达大中华区A","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309165057a45af78b&s=b","article_id":"2618649942","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309165057a45af78b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2618649942","pubTimestamp":1773041777,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近日，京东健康旗下循证医学AI工具“京东知医”正式完成新一轮升级。此次升级以循证能力的深度强化为核心，同时京东健康专家委员会正式加入“京东知医”产品共建，进一步从专业权威性与临床可信度层面为产品保驾护航。02专家委员会加持专业力量驱动产品进化伴随此次升级，京东健康专家委员会正式与“京东知医”建立全面深度共建机制，标志着顶尖临床力量对AI产品从专业指引迈向体系化、全链路的深度参与。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"89618":"京东集团-SWR","LU0048580855.USD":"富达大中华区A","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU0293314216.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"A\" (USD) ACC","IE00B29SXG58.USD":"FSSA CHINA FOCUS \"I\" (USD) ACC","LU0359201612.USD":"贝莱德中国基金A2","BK1575":"同股不同权","LU1282651048.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AMG\" (USD) INC","BK1610":"ETF&股票定投概念","LU0348805143.USD":"ALLIANZ ENHANCED ALL CHINA EQUITY \"A\" (USD) INC","LU1720050803.USD":"安联全方位中国股票基金","LU0588545490.SGD":"Eastspring Investments - Asian Equity Income AS SGD","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","JD":"京东","LU0231483743.USD":"abrdn SICAV I - ALL CHINA SUSTAINABLE EQUITY \"A\" (USD) ACC","LU0149721374.USD":"HSBC GIF HONG KONG EQUITY \"AD\" INC","LU1719994722.HKD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (HKD) ACC","LU0791590937.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"A\" (USD)","LU1282649810.SGD":"Allianz Asian Multi Income Plus Cl AMg DIS H2-SGD","LU1770034418.SGD":"ALL CHINA EQUITY \"A\" (SGDHDG) ACC","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","LU0359201885.HKD":"BGF CHINA \"A2\" (HKD) ACC","06618":"京东健康","LU0499858602.USD":"NINETY ONE GSF ASIA PACIFIC EQUITY OPPORTUNITIES \"A\" (USD) ACC","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","IE0032431581.USD":"PINEBRIDGE GREATER CHINA EQUITY \"A\" (USD) ACC","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","LU0868486357.SGD":"JPMorgan Funds - Emerging Markets Opportunities A (acc) SGD-H","LU1366334651.USD":"ALLSPRING EMERGING MARKETS EQUITY INCOME \"I\" (USD) INC","SG9999002562.SGD":"LionGlobal Asia Pacific SGD","LU1251922891.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) ACC","LU1770036033.HKD":"NINETY ONE GSF ASIAN EQUITY \"A\" (HKD) ACC","LU0594300419.USD":"富达中国消费基金A","LU0650527681.SGD":"Fidelity China Consumer A-SGD","09618":"京东集团-SW","LU1303224171.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) INC","LU2257852520.SGD":"JPMorgan Funds - Asia Growth A (acc) SGD","LU0128522157.USD":"TEMPLETON ASIAN GROWTH \"A\" ACC","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU0320764755.SGD":"FTIF - Templeton Asian Growth A Acc SGD","LU0871576103.HKD":"HSBC GIF CHINESE EQUITY \"AC\" (HKD) ACC","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU1282649067.USD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AMG\" (USD) INC A","LU0431992006.USD":"摩根大通新兴市场机会A（acc）","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","BK1502":"双十一","LU0469268626.HKD":"AB FCP I-ASIA EX JAPAN EQUITY PTF(AD","LU0499858438.USD":"NINETY ONE GSF ASIA PACIFIC EQUITY OPPORTUNITIES \"A\" (USD) INC","LU1044875133.USD":"天利亚洲反向股票 AU Acc","SG9999001226.SGD":"UNITED SUSTAINABLE ASIA TOP 50 \"A\" (SGD) ACC","LU0259732245.USD":"EASTSPRING INVESTMENTS DRAGON PEACOCK A","LU0029875118.USD":"TEMPLETON ASIAN GROWTH \"A\" INC","BK1142":"互联网与直销零售","LU1328277881.USD":"MANULIFE GF DRAGON GROWTH FUND \"AA\" (USD) INC","LU0828237510.HKD":"SCHRODER ISF BIC (BRAZ IN CH)\"A\" (HKD) ACC","LU0672654166.SGD":"FTIF - Templeton Asian Growth A (acc) SGD-H1","BK1588":"回港中概股","LU0228659784.USD":"施罗德金砖四国基金","LU0314109678.HKD":"MANULIFE GF DRAGON GROWTH \"AA\" (HKD) INC","LU0370786039.SGD":"Fidelity Greater China A-SGD","LU0051755006.USD":"摩根大通中国A (dist)","LU0543330483.HKD":"TEMPLETON ASIAN GROWTH \"A\" (HKD) ACC","LU1044876610.USD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"ZU\" (USD) ACC","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","LU1366334578.USD":"ALLSPRING EMERGING MARKETS EQUITY INCOME \"A\" (USD) INC","LU0865486749.SGD":"Eastspring Investments - Asian Equity Income AS SGD-H","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","BK1615":"港股-互联网","LU1642822792.SGD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"A\" (SGD) ACC","LU1481107354.HKD":"HSBC GIF HONG KONG EQUITY \"AD\" (HKD) INC","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","BK1619":"稳定币概念","LU1044874839.SGD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"AGH\" (SGDHDG) ACC","LU0084288322.USD":"Natixis Asia Equity RD USD","LU0164865239.USD":"HSBC GIF CHINESE EQUITY \"AC\" (USD) ACC","SG9999002828.SGD":"Eastspring Investments Unit Trusts - Dragon Peacock A SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU1813983027.USD":"MANULIFE GF DRAGON GROWTH \"AA\" (USD) INC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU1282651121.HKD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AMG\" (HKD) INC","LU0228367735.SGD":"Eastspring Investments - Asian Equity Fund AS SGD","LU0345775950.USD":"NINETY ONE GSF ASIAN EQUITY \"A\" (USD) ACC","LU0163747925.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY A ACC","BK1249":"综合零售","LU0140636845.USD":"施罗德大中华区股票A Acc","LU0164880469.USD":"HSBC GIF HONG KONG EQUITY \"AC\" ACC","LU0211977185.USD":"EASTSPRING INVESTMENTS GREATER CHINA EQUITY \"A\" ACC","LU0588545904.SGD":"Eastspring Investments - Asian Equity Income ASDM SGD","LU0588545730.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY INCOME \"ADM\" (USD) INC","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","LU1808992512.USD":"AB ALL CHINA EQUITY PORTFOLIO \"A\" (USD) ACC","IE00B3M56506.USD":"NEUBERGER BERMAN EMERGING MARKETS EQUITY \"A\" (USD) ACC","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","BK1591":"就地过年概念","LU0791591158.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"I\" (USD) ACC","LU0531971595.HKD":"HSBC GIF CHINESE EQUITY \"AD\" (HKD) INC","LU0052750758.USD":"富兰克林中国基金A Acc","LU0384037296.USD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AT\" (USD) ACC","LU0488056044.USD":"Allianz Asian Multi Income Plus Cl AM DIS USD","IE00BGV7N243.SGD":"FSSA Global Emerging Markets Focus I Acc SGD","LU0345776255.USD":"NINETY ONE GSF ASIAN EQUITY \"A\" (USD) INC","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU0315178854.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY INCOME \"A\" ACC","LU1224444064.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AM\" (USDHDG) INC","LU0315179316.USD":"EASTSPRING INVESTMENTS ASIAN DYNAMIC \"A\" (USD) ACC"},"translate_title":"Expert Committee Blessing + Evidence-Based Ability Enhancement! \"Jingdong Zhiyi\" welcomes comprehensive upgrade","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"89618":0.6,"JD":0.6,"06618":1.93,"09618":0.9},"content_text":"近日，京东健康旗下循证医学AI工具“京东知医”正式完成新一轮升级。此次升级以循证能力的深度强化为核心，同时京东健康专家委员会正式加入“京东知医”产品共建，进一步从专业权威性与临床可信度层面为产品保驾护航。自今年1月发布以来，“京东知医”凭借精准的临床循证与高效的科研辅助能力，受到广大医生的认可。目前，“知医”已全面集成于京东医生App，并向全体医生免费开放使用，无论是否已入驻京东健康平台，均可直接下载京东医生App体验，能随时随地一站式获取临床循证检索、科研文献解读与智能诊疗辅助等服务。01自研大模型循证能力升级持续减少模型幻觉此次京东知医功能迎来重要升级，核心是对自研循证增强医疗大模型进行全面迭代优化。新版模型聚焦高可信、强严谨的循证医疗场景，通过深度融合引用奖励模型与事实感知强化学习技术，在训练与推理全流程中，确保模型输出严格遵循医学证据与临床逻辑，提升医疗信息准确性与专业性，降低医疗实体关系及引用层面的偏差问题，为医生提供更可靠、更规范的循证医学服务。值得关注的是，新版模型新增医生场景自适应审慎生成机制，可根据不同使用场景动态调整表述严谨度与边界：在病例研判、疑难会诊等高风险场景，强化审慎表达与多证据交叉验证；在文献解读、诊疗方案制定等场景，则兼顾专业性与实操性，实现场景适配与风险可控。经医疗安全性、事实一致性、证据完整度、边界合规性四大维度系统评测，新版模型在权威医疗问答基准上的幻觉率显著下降，同时全面提升了审慎表述合规性、临床事实一致性和内容引用准确性，从生成风格、表述逻辑、临床合规性三个核心维度，强化了医疗AI的安全性与可信度。自今年1月发布以来，京东知医凭借精准的循证能力和高效的科研辅助体验获得广大医生认可，2月医生用户数环比大幅增加。依托涵盖超4000万份全球医学文献、4万份诊疗指南及3万余份药品说明书的专业知识底座，京东知医将持续为医生在临床循证诊疗、复杂病例决策、科研辅助等方面提供有力支持。02专家委员会加持专业力量驱动产品进化伴随此次升级，京东健康专家委员会正式与“京东知医”建立全面深度共建机制，标志着顶尖临床力量对AI产品从专业指引迈向体系化、全链路的深度参与。京东健康专家委员会于2025年1月正式成立，截至目前已汇聚近400名专委会成员，均来自复旦专科排行榜前十医院各专科的主任级别医师，覆盖全国各学科顶尖专家力量。此次产品升级后，京东健康专家委员会将全面、系统性地参与\"京东知医\"的循证内容审核、临床场景验证与产品功能迭代，从源头保障AI生成内容的权威性与规范性，推动临床循证医学与科研AI的高标准发展。这一合作的建立，也是京东健康将经长期积淀打磨的专家资源与服务能力进一步开放的重要体现。未来，专家委员会将与“京东知医”持续深化协同，推动医疗卫生资源优化配置，持续提高互联网医疗服务水平，与京东健康共绘医疗服务行业新生态格局，为医院和医生提供一体化解决方案。多位专家在实际使用后给予了高度评价。中国抗癌协会肿瘤大数据与真实世界研究专委会主任委员惠周光表示，复杂病例诊疗，证据越全越安心。“知医”精准检索、系统整理、原文溯源，让每一次决策都有高质量依据支撑。中山大学附属第一医院内分泌科主任李延兵认为，临床决策容不得半点含糊，“知医”以权威文献为依据、以清晰溯源为底线，让循证诊疗更可信、更高效。广州市妇女儿童医疗中心儿童保健科专科主任胡丹丹则指出，从海量文献到精准结论，“知医”重构了医学信息获取方式。标注可查、来源可靠，是医生身边值得信赖的循证助手。“京东知医”持续升级的背后，是京东健康在医疗AI纵深领域的持续推进。依托京医千询医疗大模型技术底座，京东健康已构建起涵盖AI京医、京东卓医等在内的AI健康全场景服务矩阵，覆盖智能分诊、24小时随访、专病诊疗与科研等多个环节。“京东知医”的加入与升级，标志着这一矩阵迈向对医生群体的深度赋能。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2618649942","isCrawlerRequest":true}